Articles dans des revues avec comité de lecture (123)
  1. 4. Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J.-B., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., Le Stang, N., TABONE-EGLINGER, S., Galateau-Salle, F., Blanquart, C., van Meerbeeck, J. P., Berghmans, T., Jean, D., & Roger, P. P. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular Oncology. doi:https://doi.org/10.1002/1878-0261.13351
  2. 5. Pita, J. M., Coulonval, K., Costante, G., Myriam, D., Emmanuelle, L., Cavaco, B. M., A, C. J., Durante, C., Maenhaut, C., Dumont, J., Roger, P. P., & Raspé, E. (2022). CDK4 phosphorylation status and rational use of CDK4/6 inhibitors in advanced thyroid cancers. Endocrine abstracts, 84(07-34). doi:10.1530/endoabs.84.OP-07-34
  3. 6. Coulonval, K., Vercruysse, V., Paternot, S., Pita, J. M., Corman, R., Raspé, E., & Roger, P. P. (2022). Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. Cell cycle (Georgetown, Tex.), 21(1), PMC8837260, 12-32. doi:10.1080/15384101.2021.1984663
  4. 7. van Caloen, G., Schmitz, S., Van Marcke, C., Caignet, X., Mendola, A., Ruys, S. P. D., Roger, P. P., Vertommen, D., & Machiels, J. P. (2021). Preclinical evaluation of the association of the cyclin-dependent kinase 4/6 inhibitor, ribociclib, and cetuximab in squamous cell carcinoma of the head and neck. Cancers (Basel), 13(6), 1251, 1-15. doi:10.3390/cancers13061251
  5. 8. Van Caloen, G., Schmitz, S., El Baroudi, M., Caignet, X., Pyr Dit Ruys, S., Roger, P. P., Vertommen, D., & Machiels, J. P. (2020). Preclinical activity of ribociclib in squamous cell carcinoma of the head and neck. Molecular cancer therapeutics. doi:10.1158/1535-7163.MCT-19-0695
  6. 9. Kyrilli, A., Paternot, S., Miot, F., Corvilain, B., Vassart, G., Roger, P. P., & Dumont, J. E. (2017). Commentary: Under appropriate conditions thyrotropin, through cyclic AMP, directly stimulates human thyrocytes proliferation in vivo and in vitro.: comment on 'Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture'. Frontiers in endocrinology, 8, 214. doi:10.3389/fendo.2017.00214
  7. 10. Raspé, E., Coulonval, K., Pita, J. M., Paternot, S., Rothé, F., Twyffels, L., Brohée, S., Ruscas-Craciun, L. I., Larsimont, D., Kruys, V., Sandras, F., Salmon, I., Van Laere, S., Piccart-Gebhart, M., Ignatiadis, M., Sotiriou, C., & Roger, P. P. (2017). CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to Palbociclib. EMBO molecular medicine, 9(8), e201607084, 1052-1066. doi:10.15252/emmm.201607084
  8. 11. Colleoni, B., Paternot, S., Pita, J. M., Bisteau, X., Coulonval, K., Davis, R., Raspé, E., & Roger, P. P. (2017). JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. Oncogene, 36(30), 4349-4361. doi:10.1038/onc.2017.7
  9. 12. Thomasz, L., Coulonval, K., Salvarredi, L., Oglio, R., Fusco, A., Rossich, L., Pisarev, M., Roger, P. P., & Juvenal, G. (2015). Inhibitory effects of 2-iodohexadecanal on FRTL-5 thyroid cells proliferation. Molecular and cellular endocrinology, 404C, 123-131. doi:10.1016/j.mce.2015.01.038
  10. 13. Mullins, G. R., Wang, L., Raje, V., Sherwood, S. G., Grande, R. C., Boroda, S., Eaton, J. M., Blancquaert, S., Roger, P. P., Leitinger, N., & Harris, T. E. (2014). Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proceedings of the National Academy of Sciences of the United States of America, 111(49), 17450-17455. doi:10.1073/pnas.1410530111
  11. 14. Paternot, S., Colleoni, B., Bisteau, X., & Roger, P. P. (2014). The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes. Cell cycle, 13(18), 2879-2888. doi:10.4161/15384101.2014.946841
  12. 15. Elong Edimo, W., Schurmans, S., Roger, P. P., & Erneux, C. (2014). SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation. Advances in biological regulation, 54C, 142-151. doi:10.1016/j.jbior.2013.09.002
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>